No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4689131 |
chr4:7496857-7496858 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs147451412 |
chr4:7496869-7496870 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs543297081 |
chr4:7496886-7496887 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs189036555 |
chr4:7496904-7496905 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs139907295 |
chr4:7496905-7496906 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs181479230 |
chr4:7496914-7496915 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs538451625 |
chr4:7496915-7496916 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs559603783 |
chr4:7496953-7496954 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs74486889 |
chr4:7497006-7497007 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs554513388 |
chr4:7497025-7497026 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs548524512 |
chr4:7497026-7497027 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs185543197 |
chr4:7497035-7497036 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs537382250 |
chr4:7497054-7497055 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs12647831 |
chr4:7497057-7497058 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs571108899 |
chr4:7497058-7497059 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs74342351 |
chr4:7497064-7497065 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs553766812 |
chr4:7497084-7497085 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs4689759 |
chr4:7497096-7497097 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs4689760 |
chr4:7497098-7497099 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs572066932 |
chr4:7497128-7497129 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs536322734 |
chr4:7497133-7497134 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs554502224 |
chr4:7497153-7497154 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs536432334 |
chr4:7497154-7497155 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs62280169 |
chr4:7497184-7497185 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs190795680 |
chr4:7497188-7497189 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs564839612 |
chr4:7497220-7497221 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs576687391 |
chr4:7497244-7497245 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs77073032 |
chr4:7497250-7497251 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs75472385 |
chr4:7497272-7497273 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs530166748 |
chr4:7497276-7497277 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs145649710 |
chr4:7497293-7497294 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs570250766 |
chr4:7497298-7497299 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs111827647 |
chr4:7497345-7497346 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs7691035 |
chr4:7497346-7497347 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs560296815 |
chr4:7497348-7497349 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs144416102 |
chr4:7497366-7497367 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs7667296 |
chr4:7497375-7497376 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
38 |
rs571174434 |
chr4:7497383-7497384 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs535307163 |
chr4:7497387-7497388 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs76166070 |
chr4:7497423-7497424 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs565654576 |
chr4:7497457-7497458 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs13119122 |
chr4:7497464-7497465 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs554646420 |
chr4:7497492-7497493 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs576862677 |
chr4:7497498-7497499 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs148758189 |
chr4:7497521-7497522 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs534729064 |
chr4:7497526-7497527 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs576007543 |
chr4:7497566-7497567 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs536858723 |
chr4:7497570-7497571 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs186522620 |
chr4:7497594-7497595 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs553068984 |
chr4:7497596-7497597 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|